Intense management of diabetes mellitus: role of glucose control and antiplatelet agents.
J Clin Pharmacol. 2004.
PMID: 15051750
Review.
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1985 | 1 |
| 1987 | 1 |
| 1989 | 1 |
| 1991 | 1 |
| 1996 | 1 |
| 1997 | 1 |
| 1998 | 1 |
| 1999 | 2 |
| 2000 | 6 |
| 2001 | 5 |
| 2002 | 9 |
| 2003 | 15 |
| 2004 | 20 |
| 2005 | 18 |
| 2006 | 19 |
| 2007 | 32 |
| 2008 | 32 |
| 2009 | 32 |
| 2010 | 48 |
| 2011 | 36 |
| 2012 | 36 |
| 2013 | 48 |
| 2014 | 37 |
| 2015 | 31 |
| 2016 | 34 |
| 2017 | 59 |
| 2018 | 41 |
| 2019 | 46 |
| 2020 | 42 |
| 2021 | 43 |
| 2022 | 45 |
| 2023 | 39 |
| 2024 | 37 |
| 2025 | 47 |
| 2026 | 10 |
Search Results
774 results
Results by year
Citations
3
articles
found by citation matching
Efficient Synthesis and in Silico Studies of the Benzimidazole Hybrid Scaffold with the Quinolinyloxadiazole Skeleton with Potential α-Glucosidase Inhibitory, Anticoagulant, and Antiplatelet Activities for Type-II Diabetes Mellitus Management and Treating Thrombotic Disorders.
ACS Omega. 2018.
PMID: 30411010
Free PMC article.
Search results
Page 1
Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management.
Cardiovasc Diabetol. 2022 May 14;21(1):74. doi: 10.1186/s12933-022-01516-6.
Cardiovasc Diabetol. 2022.
PMID: 35568946
Free PMC article.
Review.
Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2 diabetes mellitus (T2DM), particularly in low- and middle-income countries. To effectively prevent the development of CVDs in T2DM, considerable effort has been made to explore nov …
Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2 diabetes mellitus (T2DM), particularly i …
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.
JAMA. 2002 May 15;287(19):2570-81. doi: 10.1001/jama.287.19.2570.
JAMA. 2002.
PMID: 12020339
Review.
CONTEXT: Complications of atherosclerosis cause most morbidity and mortality in patients with diabetes mellitus. Despite the frequency and severity of disease, proven medical therapy remains incompletely understood and underused. ...Data extraction was perfor …
CONTEXT: Complications of atherosclerosis cause most morbidity and mortality in patients with diabetes mellitus. Despite the f …
Antiplatelet therapies in diabetes.
Diabet Med. 2020 May;37(5):726-734. doi: 10.1111/dme.14291. Epub 2020 Mar 26.
Diabet Med. 2020.
PMID: 32141628
Review.
The current review is focused on the role of antiplatelet agents in modulating the thrombotic milieu in diabetes and improving vascular outcome in this high-risk population. ...The overall aim of this review is to provide the healthcare professional with a pragmatic …
The current review is focused on the role of antiplatelet agents in modulating the thrombotic milieu in diabetes and improving …
Evidence-Based Cardiovascular Risk Management in Diabetes.
Am J Cardiovasc Drugs. 2019 Oct;19(5):439-448. doi: 10.1007/s40256-019-00336-6.
Am J Cardiovasc Drugs. 2019.
PMID: 30793262
Review.
Multipronged risk management in diabetes has contributed to the recent decline in cardiovascular mortality. ...While antiobesity medications have a modest role in managing obesity, bariatric surgery in people with body mass index (BMI) 40 or 35 with comor …
Multipronged risk management in diabetes has contributed to the recent decline in cardiovascular mortality. ...While antiobesi …
De-Escalation Dual Antiplatelet Strategy in Stabilized Myocardial Infarction Patients With Diabetes Mellitus.
JACC Cardiovasc Interv. 2025 Nov 24;18(22):2713-2724. doi: 10.1016/j.jcin.2025.09.026.
JACC Cardiovasc Interv. 2025.
PMID: 41297983
Clinical Trial.
BACKGROUND: Diabetes mellitus (DM) is associated with suboptimal clopidogrel response and elevated thrombotic risk. The benefit of early de-escalation of dual antiplatelet therapy (DAPT) in DM patients with myocardial infarction (MI) undergoing percutaneous c …
BACKGROUND: Diabetes mellitus (DM) is associated with suboptimal clopidogrel response and elevated thrombotic risk. The benefi …
Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review.
Cardiovasc Diabetol. 2024 Jun 26;23(1):220. doi: 10.1186/s12933-024-02325-9.
Cardiovasc Diabetol. 2024.
PMID: 38926722
Free PMC article.
Review.
Lower extremity peripheral artery disease (PAD) often results from atherosclerosis, and is highly prevalent in patients with type 2 diabetes mellitus (T2DM). ...Indeed, the management of PAD in patients with T2DM requires a multidisciplinary and indivi …
Lower extremity peripheral artery disease (PAD) often results from atherosclerosis, and is highly prevalent in patients with type 2 …
Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction.
Circulation. 2019 Feb 19;139(8):1047-1056. doi: 10.1161/CIRCULATIONAHA.118.037137.
Circulation. 2019.
PMID: 30586725
Free PMC article.
BACKGROUND: Sex differences are known to exist in the management of older patients presenting with acute myocardial infarction (AMI). Few studies have examined the incidence and risk factors of AMI among young patients, or whether clinical management differs by sex. …
BACKGROUND: Sex differences are known to exist in the management of older patients presenting with acute myocardial infarction (AMI). …
Management of Acute Coronary Syndromes in Patients with Diabetes.
J Fam Pract. 2017 Dec;66(12 Suppl):supp_az_1217.
J Fam Pract. 2017.
PMID: 29300792
Review.
Given the heightened risk for adverse cardiovascular outcomes in patients with diabetes mellitus, it is important that primary care clinicians be comfortable with the routine management of acute coronary syndromes (ACS) in this patient population. Notably, pa …
Given the heightened risk for adverse cardiovascular outcomes in patients with diabetes mellitus, it is important that primary …
Sex Differences in Type-2 Diabetes: Implications for Cardiovascular Risk Management.
Curr Pharm Des. 2017;23(10):1471-1476. doi: 10.2174/1381612823666170130153704.
Curr Pharm Des. 2017.
PMID: 28137219
Review.
BACKGROUND: Among individuals with Type 2 diabetes (T2DM), cardiovascular disease (CVD) is the leading cause of morbidity and mortality. ...METHODS: The aim of this review is to clarify, in a sex and gender perspective, the impact of diabetes in CVD risk and …
BACKGROUND: Among individuals with Type 2 diabetes (T2DM), cardiovascular disease (CVD) is the leading cause of morbidity and …
Management of Cardiovascular Risk in Perimenopausal Women with Diabetes.
Diabetes Metab J. 2021 Jul;45(4):492-501. doi: 10.4093/dmj.2020.0262. Epub 2021 Jul 30.
Diabetes Metab J. 2021.
PMID: 34352986
Free PMC article.
Review.
Cardiovascular disease is the primary cause of mortality in women and men with diabetes. Due to age and worsening of risk factors over the menopausal transition, risk of coronary heart disease events increases in postmenopausal women with diabetes. Ran …
Cardiovascular disease is the primary cause of mortality in women and men with diabetes. Due to age and worsening of risk fact …
Cite